Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fourie

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|October 31, 2009
Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolaseAnne M Fourie
Journal of Leukocyte Biology|September 11, 2012
Targeting the Th17 pathway in psoriasisM Merle Elloso, Mireia Gomez-Angelats, Anne M Fourie
The Journal of Biological Chemistry|June 5, 2003
Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23Anne M Fourie, Fawn Coles, Veronica Moreno, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cellsKatherine A Lundeen, Binggang Sun, Lars Karlsson, et al.
Arthritis Research & Therapy|August 6, 2024
The mode of action of IL-23 in experimental inflammatory arthritic pain and diseaseKevin M-C Lee, Tanya Lupancu, Leon Chang, et al.
Cytokine|April 26, 2024
IL-23 regulation of myeloid cell biology during inflammationKevin M-C Lee, Tanya Lupancu, Leon Chang, et al.
American Journal of Respiratory and Critical Care Medicine|January 30, 2010
Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsivenessNavin L Rao, Jason P Riley, Homayon Banie, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2007
Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileutonNavin L Rao, Paul J Dunford, Xiaohua Xue, et al.
Scientific Reports|May 27, 2021
Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534Xiaohua Xue, Aimee De Leon-Tabaldo, Rosa Luna-Roman, et al.
Scientific Reports|April 7, 2022
Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534Xiaohua Xue, Aimee De Leon-Tabaldo, Rosa Luna-Roman, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Opinion in Investigational Drugs (London, England : 2000)|October 31, 2009
Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolaseAnne M Fourie
Journal of Leukocyte Biology|September 11, 2012
Targeting the Th17 pathway in psoriasisM Merle Elloso, Mireia Gomez-Angelats, Anne M Fourie
The Journal of Biological Chemistry|June 5, 2003
Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23Anne M Fourie, Fawn Coles, Veronica Moreno, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cellsKatherine A Lundeen, Binggang Sun, Lars Karlsson, et al.
Arthritis Research & Therapy|August 6, 2024
The mode of action of IL-23 in experimental inflammatory arthritic pain and diseaseKevin M-C Lee, Tanya Lupancu, Leon Chang, et al.
Cytokine|April 26, 2024
IL-23 regulation of myeloid cell biology during inflammationKevin M-C Lee, Tanya Lupancu, Leon Chang, et al.
American Journal of Respiratory and Critical Care Medicine|January 30, 2010
Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsivenessNavin L Rao, Jason P Riley, Homayon Banie, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2007
Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileutonNavin L Rao, Paul J Dunford, Xiaohua Xue, et al.
Scientific Reports|May 27, 2021
Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534Xiaohua Xue, Aimee De Leon-Tabaldo, Rosa Luna-Roman, et al.
Scientific Reports|April 7, 2022
Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534Xiaohua Xue, Aimee De Leon-Tabaldo, Rosa Luna-Roman, et al.
Pageof 3